Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate priorities
Stabilization and early escalation
Airway and breathing
Hypoxemia
Increased work of breathing
Aspiration risk
Circulation
Two large bore IV
Cardiac monitoring
Point of care glucose mmol/l
Sepsis screening
Suspected infection plus organ dysfunction
Hypotension MAP < 65 mmHg
Lactate mmol/l elevated
Early antibiotics timing
If septic shock then antibiotics within 1 hour
If sepsis without shock then antibiotics within 3 hours
Early source control planning
IR and gynecology notification after imaging suspicion
OR readiness if rupture concern
Hemodynamic targets and monitoring
Perfusion goals
MAP at least 65 mmHg
If persistent hypotension after fluids then vasopressor
Urine output at least 0.5 ml/kg/hour
Foley catheter if severe illness or shock
Lactate clearance trend
Repeat lactate within 2 to 4 hours if elevated
Continuous reassessment triggers
Worsening pain with guarding
Rising lactate mmol/l
New fever or rigors
High risk phenotypes
Time critical presentations
Suspected rupture
Sudden generalized abdominal pain
Peritonitis
Hypotension
Septic shock
Altered mental status
Cold extremities
Refractory hypotension
Necrotizing pelvic infection
Severe pain out of proportion
Skin crepitus perineum
Rapid systemic toxicity
History
Focused symptom profile
Presenting features
Pelvic or lower abdominal pain
Onset and progression
Unilateral predominance
Fever or chills
Peak temperature at home
Antipyretic use
Vaginal discharge
Purulent or malodorous
New bleeding
Gastrointestinal symptoms
Nausea or vomiting
Anorexia
Urinary symptoms
Dysuria
Frequency
Pregnancy possibility
Last menstrual period timing
Contraception use
Risk factors and exposures
Infection and procedural risks
Prior PID
Prior TOA
Recent STI exposure
New partner
Multiple partners
IUD presence
Placement within past 3 weeks
Recent uterine instrumentation
D and C
Hysteroscopy
Postpartum or postabortion state
Symptoms within 6 weeks
Immunocompromise
Diabetes
Chronic steroids
HIV
Endometriosis or pelvic surgery
Adhesions risk
Clinical course and prior treatment
Timeline and response
Symptom duration
More than 72 hours
Prior antibiotics
Agent and days taken
Missed doses
Prior imaging results
Outside ultrasound report
Analgesic and antipyretic response
Persistent severe pain
Physical Exam
Vital signs and general
Systemic illness assessment
Temperature
Persistent fever
Heart rate
Tachycardia
Blood pressure
Hypotension
Respiratory rate
Tachypnea
Oxygen saturation
Hypoxemia
Mental status
Confusion
Lethargy
Abdominal and pelvic
Abdominal exam
Suprapubic tenderness
Rebound
Guarding
Peritonitis signs
Rigid abdomen
Diffuse tenderness
Mass effect
Palpable adnexal fullness
Pelvic exam
Speculum findings
Mucopurulent discharge
Cervicitis
Bimanual findings
Cervical motion tenderness
Adnexal tenderness
Adnexal mass
PITFALLS
Severe pain limiting exam
Normal pelvic exam does not exclude TOA
Adjacent sites and complications
Alternative sources and extension
CVA tenderness
Pyelonephritis mimic
Right lower quadrant localized peritoneal signs
Appendicitis mimic
Perineal skin
Cellulitis
Crepitus
Differential Diagnosis
Life threatening and surgical mimics
Surgical emergencies
Ectopic pregnancy ICD-10 O00
Positive pregnancy test
Free fluid
Appendicitis ICD-10 K35
RLQ peritoneal signs
Ovarian torsion ICD-10 N83.5
Sudden severe unilateral pain
Ruptured hemorrhagic ovarian cyst ICD-10 N83.2
Acute pain with hemoperitoneum
Bowel obstruction ICD-10 K56
Distension
Obstipation
Perforated viscus ICD-10 K63.1
Free air
Critical infections
Sepsis source non pelvic ICD-10 A41.9
Alternate focus
Fournier gangrene ICD-10 N49.3
Perineal necrosis
Pyelonephritis ICD-10 N10
CVA tenderness
Urinalysis infection
Gynecologic and pelvic conditions
Gynecologic causes
PID without abscess ICD-10 N73.9
Cervicitis plus pelvic tenderness
Endometritis ICD-10 N71
Postpartum or postprocedure
Degenerating fibroid ICD-10 D25
Known leiomyoma
Endometriosis flare ICD-10 N80
Cyclic pain pattern
Malignancy with necrosis ICD-10 C56
Weight loss
Complex mass
Urologic and GI overlaps
Ureterolithiasis ICD-10 N20
Colicky flank pain
Hematuria
Diverticulitis ICD-10 K57
LLQ pain
CT colitis
Laboratory Tests
Core evaluation
Initial labs
Pregnancy test
Serum beta hCG if urine equivocal
Complete blood count
Leukocytosis support
Normal WBC does not exclude TOA
CMP
Creatinine for contrast planning
Transaminitis possible in PID
Lactate mmol/l if systemic toxicity
Serial trend for resuscitation
Blood cultures if febrile or septic
Two sets before antibiotics if no delay
Urinalysis
Pyuria overlap common
Culture if UTI concern
Microbiology and STI testing
Genital infection testing
NAAT gonorrhea and chlamydia
Vaginal or endocervical specimen
Trichomonas testing
NAAT if available
Vaginitis testing
BV markers
Candida if symptomatic
HIV testing
Offer per local policy
Syphilis serology
If STI risk
Inflammatory and coagulation adjuncts
Adjunct tests when indicated
CRP trend
Baseline for response
ESR
Limited acute utility
Coagulation panel if severe illness or procedure planned
INR
Platelets
Type and screen if rupture concern
Transfusion readiness
Diagnostic Tests
Scoring Systems
Severity and sepsis tools
qSOFA
Altered mentation
Respiratory rate at least 22 per minute
Systolic blood pressure at most 100 mmHg
SIRS
Temperature abnormal
Heart rate more than 90
Respiratory rate more than 20
WBC abnormal
Shock index
HR divided by SBP more than 0.9 concern
Clinical application
High score then early ICU and source control planning
Low score does not exclude TOA
MRI
Pelvic MRI
Indications
Equivocal ultrasound and CT
Contrast avoidance preference when stable
Findings supporting TOA
Complex thick walled adnexal collection
Restricted diffusion
Surrounding inflammatory change
Limitations
Limited availability emergently
Time burden in unstable patient
CT
CT abdomen pelvis with IV contrast
Indications
Concern for alternate diagnosis
Suspected rupture or complications
Poor ultrasound window
Findings supporting TOA
Rim enhancing adnexal collection
Tubal thickening
Pelvic fat stranding
Gas within collection possible anaerobes
Complication assessment
Free fluid with peritonitis concern
Abscess extension
Bowel involvement
Procedure planning
CT guidance feasibility for drainage
Ultrasound
Transvaginal ultrasound
First line imaging
Evaluate ovaries and tubes
Evaluate free fluid
Findings supporting TOA
Complex multiloculated adnexal mass
Thick irregular walls
Internal echoes or debris
Adjacent hydrosalpinx or pyosalpinx
Doppler pearls
Hyperemia around complex mass
Preserved flow does not exclude torsion
PITFALLS
TOA mimics hemorrhagic cyst and endometrioma
Early TOA may appear as complex cystic mass
Disposition
Level of care
Admission indications
Suspected or confirmed TOA
Inpatient IV antibiotics default
Pregnancy
Inpatient management
Severe illness
High fever
Persistent vomiting
Inability to tolerate PO
Sepsis or shock
ICU consideration
Failure of outpatient PID therapy
No improvement within 48 to 72 hours
ICU criteria
Vasopressor requirement
Norepinephrine infusion
Lactate mmol/l persistently elevated
Worsening organ dysfunction
Altered mental status
Airway concern
Consultation and transfer
Specialist involvement
Gynecology
All TOA cases
Interventional radiology
Abscess drainage candidate
General surgery
Appendicitis overlap
Bowel involvement
Transfer triggers
No gynecology coverage
High risk rupture
Need for IR drainage unavailable
Persistent fever after 48 to 72 hours IV therapy
Discharge criteria
Limited discharge scenarios
Clinically improved after inpatient course
Afebrile at least 24 hours
Pain controlled on oral meds
Tolerating oral intake
Reliable follow up within 72 hours
Gynecology appointment arranged
Oral antibiotic completion plan
Total duration at least 14 days
Treatment
Analgesia and supportive care
Symptom control and monitoring
Analgesia
Acetaminophen 1000 mg PO or IV every 6 hours as needed
Ibuprofen 400 to 600 mg PO every 6 hours as needed if no contraindication
Hydromorphone 0.2 to 0.5 mg IV every 2 to 3 hours as needed
Antiemetic
Ondansetron 4 mg IV or PO every 6 to 8 hours as needed
Fluids
Crystalloid bolus 20 to 30 ml/kg if hypotension or lactate elevation
Reassess after each bolus with MAP and urine output
VTE prophylaxis if admitted
Mechanical prophylaxis
Pharmacologic prophylaxis per bleeding risk
Empiric IV antibiotics
Broad spectrum pelvic infection coverage
Coverage targets
Gonorrhea and chlamydia
Anaerobes including BV associated flora
Gram negative enterics
Streptococci
Preferred inpatient regimens
Ceftriaxone based regimen
Ceftriaxone 1 g IV every 24 hours
Dose 2 g IV every 24 hours if severe sepsis or high BMI per local protocol
Doxycycline 100 mg IV or PO every 12 hours
Switch to PO when tolerating
Metronidazole 500 mg IV or PO every 12 hours
Continue anaerobic coverage for TOA
Cefoxitin based regimen
Cefoxitin 2 g IV every 6 hours
Alternative if ceftriaxone unavailable
Doxycycline 100 mg IV or PO every 12 hours
Switch to PO when tolerating
Metronidazole 500 mg IV or PO every 12 hours
Continue for TOA
Clindamycin gentamicin regimen
Clindamycin 900 mg IV every 8 hours
Anaerobe coverage strong
Gentamicin IV once daily dosing
5 to 7 mg/kg actual body weight IV every 24 hours
Dose adjust for renal function
Beta lactam allergy considerations
Clindamycin gentamicin regimen
Clindamycin 900 mg IV every 8 hours
Monitor for C difficile risk
Gentamicin 5 to 7 mg/kg IV every 24 hours
Trough monitoring per local policy
If anaphylaxis history and gentamicin unsuitable then ID consult
Alternative regimens based on local resistance
Transition to oral therapy
Clinical improvement and afebrile at least 24 hours
Doxycycline 100 mg PO every 12 hours
Continue to complete 14 days total
Metronidazole 500 mg PO every 12 hours
Continue to complete 14 days total
Source control and procedures
Abscess management strategy
Medical therapy first
Hemodynamically stable
No peritonitis
Drainage indications
No improvement after 48 to 72 hours IV antibiotics
Large abscess size
Persistent fever
Persistent leukocytosis
Surgical indications
Rupture suspicion
Generalized peritonitis
Septic shock with uncontrolled source
Concern for malignancy or torsion
Drainage approaches
Transvaginal ultrasound guided drainage
Preferred when accessible
CT guided percutaneous drainage
Consider if transvaginal not feasible
Intraoperative options
Laparoscopy washout
Tube and ovary preservation if feasible
Salpingo oophorectomy
If necrosis or rupture and unstable
IUD management
Do not remove immediately if improving on antibiotics
Reassess at 48 to 72 hours
If no improvement then consider removal
Shared decision making with gynecology
Sepsis and shock therapies
Hemodynamic support
Vasopressor
Initiate norepinephrine if MAP < 65 after fluids
Start 0.05 to 0.1 mcg/kg/min
Titrate every 2 to 5 minutes to MAP goal
Second line vasopressor
Add vasopressin 0.03 units/min if escalating norepinephrine
Avoid titration above 0.03 units/min per typical protocol
Steroid consideration
If refractory shock then hydrocortisone 50 mg IV every 6 hours
Class IIa recommendation based on sepsis guideline consensus
Early reassessment
Repeat lactate mmol/l
Bedside ultrasound for volume status
Urine output monitoring
Special Populations
Pregnancy
Pregnancy specific approach
Risk profile
TOA uncommon but higher maternal fetal risk
Ectopic exclusion mandatory
Imaging
Ultrasound first line
MRI preferred if further imaging needed and stable
Antibiotics
Avoid doxycycline
Use pregnancy compatible regimen with OB and ID input
Cephalosporin plus metronidazole options
Tailor to gestational age and allergies
Disposition
Inpatient management
Obstetrics involvement early
Geriatric
Older adult considerations
Atypical presentation
Less fever
Baseline leukopenia possible
Malignancy concern with complex adnexal mass
Lower threshold gynecologic oncology input
Medication risks
Renal dosing for gentamicin
QT risks with antiemetics
Disposition
Lower threshold ICU for sepsis physiology
Pediatrics
Adolescent and pediatric considerations
Differential emphasis
Appendicitis common mimic
Ovarian torsion high priority
STI testing and safeguarding
Confidential sexual history framework
Mandatory reporting per jurisdiction when indicated
Antibiotic dosing
Weight based dosing per pediatric protocols
Early pediatric gynecology involvement
Disposition
Inpatient management typical for TOA
Background
Epidemiology
Population patterns
Relationship to PID
TOA complication of ascending genital tract infection
Risk factors
Prior PID increases risk
STI exposure increases risk
Outcomes
Infertility risk increases with recurrent PID
Chronic pelvic pain risk increases after PID
Microbiology patterns
Polymicrobial common
Anaerobes frequent
Pathophysiology
Disease mechanism
Ascending infection
Cervix to endometrium
Fallopian tubes
Adjacent ovary involvement
Abscess formation
Tubal obstruction and pus accumulation
Adhesions and loculations
Systemic inflammation
Cytokine mediated fever and tachycardia
Progression to sepsis possible
Complications
Rupture with peritonitis
Bacteremia
Adhesions with infertility
Therapeutic Considerations
Treatment principles
Early broad spectrum antimicrobials
Cover anaerobes for TOA
Source control when not responding
Drainage improves outcomes in selected patients
Duration
Total antibiotic course at least 14 days
Guideline alignment
CDC PID guidance supports inpatient broad spectrum regimens for TOA
Class I recommendation for urgent surgical management if rupture or generalized peritonitis
Follow up and partner management
STI treatment for partners when GC or CT suspected or confirmed
Retesting for GC and CT after treatment per STI guidance
Patient Discharge Instructions
copy discharge instructions
Discharge education and safety net
Diagnosis
Tubo ovarian abscess treated with antibiotics
Medications
Finish all antibiotics to complete at least 14 days total therapy
Avoid alcohol while taking metronidazole and for 48 hours after last dose
Activity and self care
Hydration
Rest
No vaginal intercourse until symptoms resolved and treatment completed
Partner and STI considerations
Partners may need testing and treatment
Avoid sex until partners treated if STI suspected
Follow up
Gynecology follow up within 48 to 72 hours after discharge or as directed
Repeat imaging if instructed or if symptoms recur
Return to ED immediately
Worsening abdominal or pelvic pain
New fainting or severe weakness
Fever
Vomiting with inability to keep fluids down
Dizziness or low blood pressure symptoms
New shoulder pain or severe bloating
Vaginal bleeding heavy
Trouble breathing
Confusion
References
Guidelines and evidence sources
Reference set
CDC Sexually Transmitted Infections Treatment Guidelines PID and TOA sections
ACOG guidance on PID and adnexal masses
Sepsis management guidelines for shock and vasopressor targets
SNOMED CT concept
Tubo ovarian abscess
ICD-10 codes
Tubo ovarian abscess N70.93
Acute salpingitis and oophoritis N70.0
PID unspecified N73.9
Sepsis unspecified organism A41.9
Evidence level notation
ACEP Level C for ED process guidance when specialty guidelines not ACEP specific
Class I for rupture or peritonitis requiring urgent operative management
Class IIa for drainage consideration after 48 to 72 hours non response
Source file
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.